ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
Quick Stats
May 21, 202657.2
AI Score
HOLD0.5
Volume Ratio
May 14, 2026
Next Earnings
12
+ve Days (30d)
12
-ve Days (30d)
ALXO Stock Summary
Last updated May 21, 2026
ALXO is currently trading at $1.99, positioned above its 200-day moving average of $1.61, indicating a long-term uptrend. The stock has a 52-week range of $0.404 to $2.66.
Technical Analysis: The 50-day moving average stands at $1.9, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 54.219, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.136, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ALXO at 57.2/100 with a HOLD recommendation.
ALXO (ALX Oncology Holdings Inc. Common Stock) Indicators
Last updated May 21, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 54.219 |
| CMF (20) | 0.136 |
| ROC (10) | 6.417 |
| ADX (14) | 14.854 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.046 |
| AROONOSC (14) | 50.0 |
| WILLAMS %R (14) | -41.053 |
| MFI (14) | 65.456 |
ALXO Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ALXO Price vs Max Options Open Interest
ALXO Max Change In Options Open Interest
ALXO Options - Sort by Max open Interest (near term)
21st May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ALXO Daily Out of Money Options - Sort by Max open Interest (near term)
21st May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ALXO Daily In the Money Options - Sort by Max open Interest (near term)
21st May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ALXO Most Active Options by Volume(near term)
21st May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ALX Oncology Holdings Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
ALXO Moving Averages Analysis
ALX Oncology Holdings Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on May 21, 2026
ALX Oncology Holdings Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on May 21, 2026
ALXO (ALX Oncology Holdings Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated May 21, 2026
| Days | MA |
|---|---|
| 10 | 2.02 |
| 20 | 1.89 |
| 30 | 1.82 |
| 50 | 1.9 |
| 100 | 1.86 |
| 200 | 1.61 |
ALXO Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 267.8 million |
| Earnings/Share ($) | -1.49 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.6493 |
| EPS Estimate Next Year ($) | -0.538 |
| WallStreet Target Price ($) | 4.6 |
| Most Recent Quarter |